FDA Adverse Event Malfunction Summary report: N

IMMULITE 2000

MDR report key: 2874356 · Received December 14, 2012

Report

Report Number
2247117-2012-00108
Event Type
Malfunction
Date Received
December 14, 2012
Date of Event
November 14, 2012
Report Date
November 16, 2012
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS
Product Code
LTJ
PMA / PMN Number
K970227
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

A SIEMENS FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED TO THE CUSTOMER SITE. AFTER EVALUATING THE INSTRUMENT AND INSTRUMENT DATA, THE FSE COULD NOT FIND ANY INSTRUMENT MALFUNCTION. THE CAUSE OF THE DISCORDANT PSA RESULTS IS UNKNOWN. THE INSTRUMENT IS PERFORMING WITHIN SPECIFICATIONS. NO FURTHER EVALUATION OF THIS DEVICE IS REQUIRED.

Description of Event or Problem · 1

DISCORDANT, FALSELY LOW PROSTATE SPECIFIC ANTIGEN (PSA) RESULTS WERE OBTAINED ON PATIENT SAMPLES ON THE IMMULITE 2000 INSTRUMENT. IT WAS DISCOVERED THAT TWO PATIENT SAMPLES HAD HIGHER RESULTS UPON RERUN. IT IS UNKNOWN WHETHER THE DISCORDANT, FALSELY LOW PSA RESULTS FOR TWO THOSE PATIENTS WERE REPORTED TO THE PHYSICIAN(S). THE CUSTOMER STATED THAT THE LABORATORY WOULD LOOK AT HISTORIES OF PATIENTS WHOSE SAMPLES RESULTED LESS THAN 0.09 NG/ML, AND RERUN SAMPLES THAT WERE NOT CONSISTENT WITH PATIENT HISTORIES. THE CUSTOMER THEN FAXED DATA FOR TWO ADDITIONAL PATIENTS WITH DISCORDANT, FALSELY LOW PSA RESULTS. FOR ONE PATIENT, THE INITIAL, DISCORDANT RESULT WAS NOT REPORTED TO THE PHYSICIAN(S). THE LABORATORY SENT THE SAMPLE TO A REFERENCE LABORATORY (ARUP) FOR THIRD GENERATION PSA TESTING. UPON RECEIVING THE REFERENCE LABORATORY'S RESULT, THEY RERAN THE PATIENT SAMPLE AND ALSO SENT TO A THIRD LABORATORY ((B)(6)) FOR BOTH TOTAL PSA AND FREE PSA TESTING. IT IS UNKNOWN WHETHER THE CORRECT RESULT WAS REPORTED TO THE PHYSICIAN(S). FOR THE OTHER PATIENT, THE INITIAL, DISCORDANT RESULT WAS REPORTED TO THE PHYSICIAN(S). THE OPERATOR QUESTIONED THE RESULT DUE TO THE PATIENT'S HISTORY, AND RERAN THE PATIENT SAMPLE IN DUPLICATE. THE CORRECT RESULT WAS THEN REPORTED TO THE PHYSICIAN(S), WITHIN ONE HOUR OF THE INITIAL RESULT BEING REPORTED. THERE WERE NO REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT PSA RESULTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 IMMULITE 2000 IMMULITE 2000 LTJ SIEMENS HEALTHCARE DIAGNOSTICS IMMULITE 2000

Patients

Seq Age Sex Outcome Treatment
1